Galera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Galera Therapeutics

10/08/2021 13:01

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted loss of 88 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 83 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Galera Therapeutics Inc's reported EPS for the quarter was a
loss of 88 cents​.
* The mean earnings estimate of analysts had risen by about 6.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Galera Therapeutics Inc shares had fallen by 12.8% this
quarter and lost 16.2% so far this year.
* The company reported a quarterly loss of $22.39 million.
* Wall Street's median 12-month price target for Galera
Therapeutics Inc is $19.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 12:01 p.m.  ​All
figures in US dollars unless otherwise stated